Microba Life Sciences Ltd has released a press release.
Q4 FY25 Quarterly Activities Report & Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Microba Life Sciences Limited on 6ix
In the deck
Story so far
Earlier from Microba Life Sciences
- Disclosure Document - Prospectus
- Strategic Investment & Equity Raise Presentation
- Reinstatement to Quotation
- Microba secures $14.5 million to drive clinical adoption
- Suspension from Quotation
Later from Microba Life Sciences
- Q4 FY25 Quarterly Investor Presentation & Webinar
- 2025 Annual Report & Appendix 4E
- Q1 FY26 Quarterly Activities Report & Appendix 4C
- Q1 FY26 Quarterly Investor Presentation & Webinar
- Microba receives $3 million R&D Tax Incentive Refund
Follow Microba Life Sciences into a list and get an email when it puts out news.
Follow Microba Life Sciences